Indian journal of pharmacology
Cure8 research brief
Why This Matters
Medication choices and adherence are central to IBD management. This study highlights that adherence was strongly associated with being in clinical remission, and that commonly used drugs included mesalamine and azathioprine — information patients and clinicians may find relevant.
Who Should Pay Attention
Adult patients with IBD (Crohn's disease or ulcerative colitis), clinicians prescribing IBD therapies, and researchers interested in pharmacotherapy patterns and adherence.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This PubMed abstract reports a small cross-sectional study (50 patients) from the Indian Journal of Pharmacology that looked at the patterns of drug use and factors linked to clinical remission in people with IBD (ulcerative colitis and Crohn's disease).
Key findings reported: mesalamine was the most commonly prescribed drug (72%), steroids in 50%, and azathioprine in 46%. About half of participants were in clinical remission, and medication adherence was the only factor that remained a significant predictor of remission on multivariate analysis.
The study also noted adverse drug reactions in 30% of patients, most commonly anemia and pancytopenia associated with azathioprine use. If you read the abstract or the paper, note this is a cross-sectional analysis of a small sample and reports associations (not causal effects).
Keep In Mind
Cross-sectional studies show associations at a single time point and cannot prove causation. The sample size is small (n=50), and results — including the high odds ratio for adherence — should be interpreted cautiously and in context of larger studies and clinical guidelines.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationIndian journal of pharmacology
AuthorsArchana Shivanna, Praveen Panchaksharimath
InstitutionDepartment of Pharmacology, Bangalore Medical College and Research Institute, Affiliated to Rajiv Gandhi University of Health Sciences, Bengaluru, Karnataka, India.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedNov 2, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
SURGICAL APPROACH, BIOLOGICAL THERAPIES, AND INFLAMMATORY MECHANISMS ASSOCIATED WITH ULCERATIVE COLITIS AND CROHN'S DISEASE
The review links specific therapies and surgical options to outcomes that matter to people with IBD — mucosal healing, lower hospitalizations, and reduced need for surgery — and highlights that combining medical and...
Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations☆ Aspectos y consideraciones generales en la enfermedad inflamatoria intestinal durante la pandemia por COVID-19
People with IBD and their clinicians need to know whether common IBD treatments change COVID-19 risk or should be stopped. This review provides practical recommendations (continue most maintenance drugs; avoid systemic...
Large Vessel Vasculitis in IBD Linked to Younger Onset, Distinct Clinical Features
This study suggests LVV can occur in people with IBD at younger ages and with distinct vascular findings, and it may arise even when gut disease is in remission. That matters for awareness, diagnosis, and coordination...